CTNNA1 and acute myeloid leukemia: Kaplan-Meier curves indicated that the patients with aberrant CTNNA1 methylation levels were found to present reduced RFS and OS in all 319 AML patients (Figure 4A and 4B, P=0.001, P=0.002, respectively).